-transparent.png){kind=logo}
Changes in the methylation pattern of genomic DNA, particularly hypermethylation of tumor suppressor genes, occur at early stages of tumor development. Errors in DNA methylation contribute to both initiation and progression of various cancers. This stimulates significant interest in searching for inhibitors of C5-DNA-methyltransferases (MTases). Here we review the known nucleoside mechanism-based reversible and irreversible inhibitors of the MTases, as well as non-nucleoside ones, and discuss their inhibitory mechanisms and application for MTase investigations and cancer therapy.
Related Publications
O V Kirsanova, and
N A Cherepanova, and
E S Gromova
February 1999,
Journal of molecular biology,
O V Kirsanova, and
N A Cherepanova, and
E S Gromova
August 2019,
Biochemistry. Biokhimiia,
O V Kirsanova, and
N A Cherepanova, and
E S Gromova
February 1999,
Journal of molecular biology,
O V Kirsanova, and
N A Cherepanova, and
E S Gromova
December 1989,
Nucleic acids research,
O V Kirsanova, and
N A Cherepanova, and
E S Gromova
March 1996,
The EMBO journal,
O V Kirsanova, and
N A Cherepanova, and
E S Gromova
May 1983,
Cell,
O V Kirsanova, and
N A Cherepanova, and
E S Gromova
January 1985,
Progress in clinical and biological research,
O V Kirsanova, and
N A Cherepanova, and
E S Gromova
July 1996,
Proceedings of the National Academy of Sciences of the United States of America,
O V Kirsanova, and
N A Cherepanova, and
E S Gromova
August 2010,
PloS one,
O V Kirsanova, and
N A Cherepanova, and
E S Gromova
January 1994,
Nucleic acids research,
